These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3199595

  • 1. Improvement of pentobarbital-induced heart failure by MCI-154, a novel and potent cardiotonic agent, in the dog heart-lung preparation.
    Satoh K, Nunoki K, Goto T, Hosono M, Hashimoto H, Sato Y, Taira N.
    Jpn J Pharmacol; 1988 Jun; 47(2):189-95. PubMed ID: 3199595
    [Abstract] [Full Text] [Related]

  • 2. Improvement by trapidil of cardiac function of the dog heart-lung preparation depressed by pentobarbital.
    Satoh K, Kawada M, Taira N.
    Jpn Heart J; 1983 May; 24(3):399-405. PubMed ID: 6876384
    [Abstract] [Full Text] [Related]

  • 3. Improvement by denopamine (TA-064) of pentobarbital-induced cardiac failure in the dog heart-lung preparation.
    Nunoki K, Goto T, Satoh K, Taira N.
    Heart Vessels; 1985 Nov; 1(4):216-9. PubMed ID: 3831029
    [Abstract] [Full Text] [Related]

  • 4. Improvement of cardiac performance by pimobendan, a new cardiotonic drug, in the experimental failing dog heart.
    Satoh K, Satoh Y, Imagawa J, Taira N.
    Jpn Heart J; 1993 Mar; 34(2):213-9. PubMed ID: 8315818
    [Abstract] [Full Text] [Related]

  • 5. Amelioration of heart failure by MDL 17043 and MDL 19205, novel positive inotropic drugs, in dog heart-lung preparations.
    Goto T, Nunoki K, Satoh K, Taira N.
    Jpn Heart J; 1985 Nov; 26(6):1011-8. PubMed ID: 2937939
    [Abstract] [Full Text] [Related]

  • 6. Improvement of cardiac performance by AR-L 115 BS, a new cardiotonic drug, in the experimental failing dog heart.
    Morita T, Satoh K, Taira N.
    Jpn Heart J; 1984 May; 25(3):439-45. PubMed ID: 6088828
    [Abstract] [Full Text] [Related]

  • 7. Effects of MCI-154, a novel cardiotonic agent, on mean circulatory filling pressure in anesthetized dogs.
    Satoh N, Abe Y, Kitada Y, Narimatsu A, Tobe A.
    Eur J Pharmacol; 1990 Jan 17; 175(3):317-22. PubMed ID: 2108868
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A, Kitada Y, Satoh N, Suzuki R, Okushima H.
    Arzneimittelforschung; 1987 Apr 17; 37(4):398-406. PubMed ID: 3606694
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC, Roebel LE, Hsieh CP, Woodward JK.
    J Cardiovasc Pharmacol; 1984 Apr 17; 6(1):35-42. PubMed ID: 6199609
    [Abstract] [Full Text] [Related]

  • 10. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA, Canter JM, Fort DJ.
    Cardiovasc Res; 1985 Aug 17; 19(8):483-94. PubMed ID: 4042115
    [Abstract] [Full Text] [Related]

  • 11. Cardiac and coronary vasodilator effects of the novel cardiotonic agent, MCI-154, assessed in isolated, blood-perfused dog heart preparations.
    Hosono M, Taira N.
    J Cardiovasc Pharmacol; 1987 Dec 17; 10(6):692-8. PubMed ID: 2450240
    [Abstract] [Full Text] [Related]

  • 12. Improved heart failure protection by FK664, a novel positive inotropic agent, in dog heart-lung preparations.
    Sudo Y, Takai M, Esumi K.
    Life Sci; 1992 Dec 17; 51(6):PL41-6. PubMed ID: 1386131
    [Abstract] [Full Text] [Related]

  • 13. [Effect of Chinese-made vesnarinone on experimental heart failure of dog].
    Du J, Yang Z.
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Jun 17; 23(2):178-80. PubMed ID: 1452153
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.
    Mochizuki N, Uchida S, Miyata H.
    J Cardiovasc Pharmacol; 1993 Jun 17; 21(6):983-95. PubMed ID: 7687727
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
    Maruyama M, Kamiya J, Kaiho T, Kobari T.
    J Cardiovasc Pharmacol; 1988 Jun 17; 12(5):579-86. PubMed ID: 2468058
    [Abstract] [Full Text] [Related]

  • 16. The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.
    Satoh K, Maruyama M, Taira N.
    Jpn Heart J; 1982 Nov 17; 23(6):975-80. PubMed ID: 7161881
    [No Abstract] [Full Text] [Related]

  • 17. Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.
    Abe Y, Kitada Y, Narimatsu A, Tobe A.
    Eur J Pharmacol; 1991 Jan 10; 192(2):279-85. PubMed ID: 2032560
    [Abstract] [Full Text] [Related]

  • 18. [Levosimendan for treatment of heart failure].
    Yasumura Y.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():169-72. PubMed ID: 17571380
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of cardiac phosphodiesterase III by the novel cardiotonic agent 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride.
    Sellin LC, Alajoutsijärvi A, Törnquist K, Fraser M, Pippuri A, Ojala I.
    Arzneimittelforschung; 1988 Dec 28; 38(12):1787-9. PubMed ID: 2854467
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G, Ningel K, Permanetter B.
    J Cardiovasc Pharmacol; 1989 Dec 28; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.